• 

  February 11, 2025

  BioSapien Extends Pre-Series A Round to $7 Million

  R.D. Solorzano

• 

  February 5, 2025

  United Therapeutics Breaks New Ground with FDA-Cleared Xenotransplantation Trial

  R.D. Solorzano

• 

  January 10, 2025

  Aspect Biosystems Secures $115M Series B to Advance Bioprinted Tissue Therapeutics

  R.D. Solorzano

• 

  December 3, 2024

  EpiBone Secures Funding Convertible Note to Drive Global Expansion of Clinical Trials

  R.D. Solorzano

• 

  December 2, 2024

  Carl Roth Partners with BIO INX to Advance 3D Bioprinting Accessibility

  R.D. Solorzano

• 

  November 27, 2024

  French Based Lattice Medical Wins Coveted US MedTech Innovator Mid-Stage Grand Prize

  R.D. Solorzano

• 

  November 26, 2024

  CELLINK’s Strategic Shift: Right-Sizing for Long-Term Profitability

  R.D. Solorzano

• 

  November 25, 2024

  Cellbricks Therapeutics Expands to the U.S., Launches Subsidiary in Cambridge, MA

  R.D. Solorzano

• 

  November 22, 2024

  BICO Divests Nanoscribe: A Strategic Shift Towards Life Sciences

  R.D. Solorzano

• 

  November 13, 2024

  Xolo Unveils Xell: An Affordable Volumetric Bioprinter for Labs

  R.D. Solorzano